Display options
Cite
Moggia E, Koti R, Belgaumkar AP, et al. Pharmacological interventions for acute pancreatitis. Cochrane Database Syst Rev. 2017;4:CD011384doi: 10.1002/14651858.CD011384.pub2.
Moggia, E., Koti, R., Belgaumkar, A. P., Fazio, F., Pereira, S. P., Davidson, B. R., & Gurusamy, K. S. (2017). Pharmacological interventions for acute pancreatitis. The Cochrane database of systematic reviews, 4CD011384. https://doi.org/10.1002/14651858.CD011384.pub2
Moggia, Elisabetta, et al. "Pharmacological interventions for acute pancreatitis." The Cochrane database of systematic reviews vol. 4 (2017): CD011384. doi: https://doi.org/10.1002/14651858.CD011384.pub2
Moggia E, Koti R, Belgaumkar AP, Fazio F, Pereira SP, Davidson BR, Gurusamy KS. Pharmacological interventions for acute pancreatitis. Cochrane Database Syst Rev. 2017 Apr 21;4:CD011384. doi: 10.1002/14651858.CD011384.pub2. PMID: 28431202; PMCID: PMC6478067.
Copy Download .nbib Format: NLM
Share it on

Cochrane Database Syst Rev. 2017 Apr 21;4:CD011384. doi: 10.1002/14651858.CD011384.pub2.

Pharmacological interventions for acute pancreatitis.

The Cochrane database of systematic reviews

Elisabetta Moggia, Rahul Koti, Ajay P Belgaumkar, Federico Fazio, Stephen P Pereira, Brian R Davidson, Kurinchi Selvan Gurusamy

Affiliations

  1. Department of General and Digestive Surgery, IRCCS Humanitas Research Hospital, Via Manzoni 56, 20089 Rozzano, Milan, Italy, 20089.
  2. Department of Surgery, Royal Free Campus, UCL Medical School, Royal Free Hospital, Pond Street, London, UK, NW3 2QG.
  3. Dept of Upper GI Surgery, Ashford and St Peter's NHS Trust, St Peter's Hospital, Guildford Road, Chertsey, Surrey, UK, KT16 0PZ.
  4. HPB and Liver Transplant Surgery, Royal Free Hospital, NHS Foundation Trust, London, UK.
  5. UCL Institute for Liver and Digestive Health, Royal Free Hospital Campus, Upper 3rd Floor, London, UK, NW3 2PF.

PMID: 28431202 PMCID: PMC6478067 DOI: 10.1002/14651858.CD011384.pub2

Abstract

BACKGROUND: In people with acute pancreatitis, it is unclear what the role should be for medical treatment as an addition to supportive care such as fluid and electrolyte balance and organ support in people with organ failure.

OBJECTIVES: To assess the effects of different pharmacological interventions in people with acute pancreatitis.

SEARCH METHODS: We searched the Cochrane Central Register of Controlled Trials (CENTRAL, 2016, Issue 9), MEDLINE, Embase, Science Citation Index Expanded, and trial registers to October 2016 to identify randomised controlled trials (RCTs). We also searched the references of included trials to identify further trials.

SELECTION CRITERIA: We considered only RCTs performed in people with acute pancreatitis, irrespective of aetiology, severity, presence of infection, language, blinding, or publication status for inclusion in the review.

DATA COLLECTION AND ANALYSIS: Two review authors independently identified trials and extracted data. We did not perform a network meta-analysis as planned because of the lack of information on potential effect modifiers and differences of type of participants included in the different comparisons, when information was available. We calculated the odds ratio (OR) with 95% confidence intervals (CIs) for the binary outcomes and rate ratios with 95% CIs for count outcomes using a fixed-effect model and random-effects model.

MAIN RESULTS: We included 84 RCTs with 8234 participants in this review. Six trials (N = 658) did not report any of the outcomes of interest for this review. The remaining 78 trials excluded 210 participants after randomisation. Thus, a total of 7366 participants in 78 trials contributed to one or more outcomes for this review. The treatments assessed in these 78 trials included antibiotics, antioxidants, aprotinin, atropine, calcitonin, cimetidine, EDTA (ethylenediaminetetraacetic acid), gabexate, glucagon, iniprol, lexipafant, NSAIDs (non-steroidal anti-inflammatory drugs), octreotide, oxyphenonium, probiotics, activated protein C, somatostatin, somatostatin plus omeprazole, somatostatin plus ulinastatin, thymosin, ulinastatin, and inactive control. Apart from the comparison of antibiotics versus control, which included a large proportion of participants with necrotising pancreatitis, the remaining comparisons had only a small proportion of patients with this condition. Most trials included either only participants with severe acute pancreatitis or included a mixture of participants with mild acute pancreatitis and severe acute pancreatitis (75 trials). Overall, the risk of bias in trials was unclear or high for all but one of the trials.

SOURCE OF FUNDING: seven trials were not funded or funded by agencies without vested interest in results. Pharmaceutical companies partially or fully funded 21 trials. The source of funding was not available from the remaining trials.Since we considered short-term mortality as the most important outcome, we presented only these results in detail in the abstract. Sixty-seven studies including 6638 participants reported short-term mortality. There was no evidence of any differences in short-term mortality in any of the comparisons (very low-quality evidence). With regards to other primary outcomes, serious adverse events (number) were lower than control in participants taking lexipafant (rate ratio 0.67, 95% CI 0.46 to 0.96; N = 290; 1 study; very low-quality evidence), octreotide (rate ratio 0.74, 95% CI 0.60 to 0.89; N = 770; 5 studies; very low-quality evidence), somatostatin plus omeprazole (rate ratio 0.36, 95% CI 0.19 to 0.70; N = 140; 1 study; low-quality evidence), and somatostatin plus ulinastatin (rate ratio 0.30, 95% CI 0.15 to 0.60; N = 122; 1 study; low-quality evidence). The proportion of people with organ failure was lower in octreotide than control (OR 0.51, 95% CI 0.27 to 0.97; N = 430; 3 studies; very low-quality evidence). The proportion of people with sepsis was lower in lexipafant than control (OR 0.26, 95% CI 0.08 to 0.83; N = 290; 1 study; very low-quality evidence). There was no evidence of differences in any of the remaining comparisons in these outcomes or for any of the remaining primary outcomes (the proportion of participants experiencing at least one serious adverse event and the occurrence of infected pancreatic necrosis). None of the trials reported heath-related quality of life.

AUTHORS' CONCLUSIONS: Very low-quality evidence suggests that none of the pharmacological treatments studied decrease short-term mortality in people with acute pancreatitis. However, the confidence intervals were wide and consistent with an increase or decrease in short-term mortality due to the interventions. We did not find consistent clinical benefits with any intervention. Because of the limitations in the prognostic scoring systems and because damage to organs may occur in acute pancreatitis before they are clinically manifest, future trials should consider including pancreatitis of all severity but power the study to measure the differences in the subgroup of people with severe acute pancreatitis. It may be difficult to power the studies based on mortality. Future trials in participants with acute pancreatitis should consider other outcomes such as complications or health-related quality of life as primary outcomes. Such trials should include health-related quality of life, costs, and return to work as outcomes and should follow patients for at least three months (preferably for at least one year).

References

  1. Vnitr Lek. 1998 Sep;44(9):524-7 - PubMed
  2. Gut. 1999 Jul;45(1):97-104 - PubMed
  3. Gut. 1999 Aug;45(2):311-6 - PubMed
  4. Hepatogastroenterology. 1999 May-Jun;46(27):1968-72 - PubMed
  5. BMJ. 2000 Jan 22;320(7229):244-5 - PubMed
  6. J Surg Res. 1975 Feb;18(2):197-200 - PubMed
  7. Hepatogastroenterology. 2000 Jul-Aug;47(34):1147-50 - PubMed
  8. Gut. 2001 Jan;48(1):62-9 - PubMed
  9. Dig Liver Dis. 2001 Jan-Feb;33(1):49-57 - PubMed
  10. J Gastrointest Surg. 2001 Mar-Apr;5(2):113-8; discussion 118-20 - PubMed
  11. Br J Surg. 2002 May;89(5):628-9; discussion 629 - PubMed
  12. Am J Gastroenterol. 2002 Jun;97(6):1557-9 - PubMed
  13. Klin Med (Mosk). 2002;80(9):44-6 - PubMed
  14. Br J Surg. 2003 Jan;90(1):123 - PubMed
  15. Przegl Lek. 1976;33(2):323-8 - PubMed
  16. Surg Gynecol Obstet. 1992 Nov;175(5):397-400 - PubMed
  17. BMJ. 2003 Sep 6;327(7414):557-60 - PubMed
  18. Chest. 1992 Jun;101(6):1644-55 - PubMed
  19. Br Med J. 1965 Sep 11;2(5462):627-9 - PubMed
  20. Pancreas. 2003 Nov;27(4):e79-83 - PubMed
  21. World J Gastroenterol. 2003 Nov;9(11):2565-9 - PubMed
  22. Int J Epidemiol. 1992 Oct;21(5):837-41 - PubMed
  23. Digestion. 1992;51(2):65-70 - PubMed
  24. Gastroenterology. 2004 Apr;126(4):997-1004 - PubMed
  25. Gastroenterology. 2004 Apr;126(4):1195-8 - PubMed
  26. Gastroenterology. 2004 Sep;127(3):1015-6; author reply 1016 - PubMed
  27. Stat Med. 2004 Oct 30;23(20):3105-24 - PubMed
  28. BMC Surg. 2004 Sep 29;4:12 - PubMed
  29. Zhong Xi Yi Jie He Xue Bao. 2005 Mar;3(2):103-7 - PubMed
  30. Clin Nutr. 2005 Apr;24(2):198-205 - PubMed
  31. Can J Surg. 2006 Apr;49(2):101-6 - PubMed
  32. Am J Gastroenterol. 2006 Jun;101(6):1348-53 - PubMed
  33. JOP. 2006 Jul 10;7(4):361-71 - PubMed
  34. Pancreas. 2006 Nov;33(4):323-30 - PubMed
  35. Stat Med. 2007 Sep 10;26(20):3681-99 - PubMed
  36. Gut. 2007 Oct;56(10):1439-44 - PubMed
  37. Ann Surg. 2007 May;245(5):674-83 - PubMed
  38. Ann Surg. 2007 May;245(5):684-5 - PubMed
  39. Scand J Gastroenterol. 2007 Jun;42(6):771-6 - PubMed
  40. Hepatogastroenterology. 2007 Mar;54(74):590-4 - PubMed
  41. J Dig Dis. 2007 May;8(2):96-102 - PubMed
  42. World J Gastroenterol. 2007 May 21;13(19):2733-7 - PubMed
  43. Pancreatology. 2007;7(5-6):531-8 - PubMed
  44. Nan Fang Yi Ke Da Xue Xue Bao. 2008 Jan;28(1):129-31 - PubMed
  45. Lancet. 2008 Feb 23;371(9613):651-659 - PubMed
  46. Arch Intern Med. 2008 Mar 24;168(6):649-56 - PubMed
  47. Lancet. 2008 Mar 29;371(9618):1072; author reply 1072 - PubMed
  48. Ned Tijdschr Geneeskd. 2008 Mar 22;152(12):685-96 - PubMed
  49. JPEN J Parenter Enteral Nutr. 2008 May-Jun;32(3):236-41 - PubMed
  50. World J Gastroenterol. 2008 May 21;14(19):2968-76 - PubMed
  51. Br J Surg. 2008 Aug;95(8):941-2 - PubMed
  52. Lancet. 2008 Jul 12;372(9633):113; author reply 114 - PubMed
  53. Ned Tijdschr Geneeskd. 2008 Jul 12;152(28):1591; author reply 1593-4 - PubMed
  54. Ned Tijdschr Geneeskd. 2008 Jul 12;152(28):1592; author reply 1592-4 - PubMed
  55. Ned Tijdschr Geneeskd. 2008 Jul 12;152(28):1591-2; author reply 1593-4 - PubMed
  56. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2008 Aug;28(8):708-10 - PubMed
  57. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2008 Sep;28(9):793-6 - PubMed
  58. J Gastrointest Surg. 2009 Apr;13(4):768-74 - PubMed
  59. Zhonghua Yi Xue Za Zhi. 2008 Sep 9;88(34):2407-9 - PubMed
  60. South Med J. 2008 Nov;101(11):1126-31 - PubMed
  61. J Gastroenterol Hepatol. 2009 May;24(5):736-42 - PubMed
  62. J Huazhong Univ Sci Technolog Med Sci. 2009 Feb;29(1):35-8 - PubMed
  63. Aliment Pharmacol Ther. 2009 Jun 1;29(11):1155-64 - PubMed
  64. Zhong Xi Yi Jie He Xue Bao. 2009 Apr;7(4):330-3 - PubMed
  65. Acta Gastroenterol Latinoam. 2009 Mar;39(1):24-9 - PubMed
  66. JPEN J Parenter Enteral Nutr. 2009 Jul-Aug;33(4):444-6 - PubMed
  67. Inflammation. 2009 Oct;32(5):304-9 - PubMed
  68. Intensive Care Med. 2009 Nov;35(11):1974-8 - PubMed
  69. Hepatogastroenterology. 1990 Feb;37(1):92-8 - PubMed
  70. Ann Surg. 2009 Nov;250(5):712-9 - PubMed
  71. Cochrane Database Syst Rev. 2010 Jan 20;(1):CD003630 - PubMed
  72. Lancet. 2010 Mar 13;375(9718):875-6 - PubMed
  73. Vnitr Lek. 2010 Feb;56(2):111-4 - PubMed
  74. Trop Gastroenterol. 2009 Oct-Dec;30(4):201-6 - PubMed
  75. Pancreas. 2010 Aug;39(6):863-7 - PubMed
  76. Cochrane Database Syst Rev. 2010 May 12;(5):CD002941 - PubMed
  77. Inflammation. 2011 Jun;34(3):198-202 - PubMed
  78. Crit Care. 2010;14(4):R139 - PubMed
  79. J Clin Epidemiol. 2011 Feb;64(2):163-71 - PubMed
  80. J Clin Gastroenterol. 2011 May-Jun;45(5):442-8 - PubMed
  81. Saudi J Gastroenterol. 2011 May-Jun;17(3):174-9 - PubMed
  82. World J Gastroenterol. 2012 Jan 21;18(3):279-84 - PubMed
  83. N Engl J Med. 2012 Apr 12;366(15):1414-22 - PubMed
  84. Magy Seb. 2012 Apr;65(2):44-51 - PubMed
  85. Acta Chir Belg. 2012 Mar-Apr;112(2):131-8 - PubMed
  86. Gastroenterology. 2012 Nov;143(5):1179-1187.e3 - PubMed
  87. Adv Exp Med Biol. 1979;120B:367-78 - PubMed
  88. JAMA. 2012 Sep 26;308(12):1246-53 - PubMed
  89. Pancreas. 2012 Nov;41(8):1206-12 - PubMed
  90. Gut. 2013 Jan;62(1):102-11 - PubMed
  91. Peptides. 2013 Feb;40:57-64 - PubMed
  92. Zhonghua Nei Ke Za Zhi. 2012 Dec;51(12):962-5 - PubMed
  93. Am J Med Sci. 2013 Nov;346(5):371-6 - PubMed
  94. Med Decis Making. 2013 Jul;33(5):618-40 - PubMed
  95. Aliment Pharmacol Ther. 2013 Sep;38(5):539-48 - PubMed
  96. Curr Opin Gastroenterol. 2013 Sep;29(5):523-30 - PubMed
  97. Am J Gastroenterol. 2013 Sep;108(9):1400-15; 1416 - PubMed
  98. Infusionsther Klin Ernahr. 1985 Jun;12(3):128-33 - PubMed
  99. Clin Biochem. 1985 Aug;18(4):224-9 - PubMed
  100. Scand J Gastroenterol. 1985 Sep;20(7):798-800 - PubMed
  101. Hepatogastroenterology. 2013 Sep;60(126):1504-8 - PubMed
  102. J Assoc Physicians India. 2013 Aug;61(8):535-8 - PubMed
  103. BMJ. 2014 Sep 24;349:g5630 - PubMed
  104. Pancreas. 2014 Nov;43(8):1194-200 - PubMed
  105. J Gastrointest Surg. 2015 Mar;19(3):480-91 - PubMed
  106. Gut. 1989 Feb;30(2):223-7 - PubMed
  107. Exp Ther Med. 2015 Mar;9(3):947-954 - PubMed
  108. J Hepatobiliary Pancreat Sci. 2015 Apr;22(4):316-21 - PubMed
  109. PLoS One. 2015 Jun 19;10(6):e0130412 - PubMed
  110. Gastroenterology. 2015 Aug;149(2):318-20.e3 - PubMed
  111. Zhonghua Yi Xue Za Zhi. 2015 May 19;95(19):1471-4 - PubMed
  112. Scand J Clin Lab Invest. 2016;76(1):10-6 - PubMed
  113. Am J Med Sci. 2016 May;351(5):506-12 - PubMed
  114. Nutr Clin Pract. 2008 Dec;23(6):662-663 - PubMed
  115. Khirurgiia (Mosk). 1977 Jul;(7):87-92 - PubMed
  116. Ugeskr Laeger. 1988 Nov 21;150(47):2902-3 - PubMed
  117. Z Gastroenterol. 1986 Apr;24(4):200-11 - PubMed
  118. Med Klin (Munich). 1988 Apr 29;83(10):320-4, 352 - PubMed
  119. Gut. 1978 Mar;19(3):175-9 - PubMed
  120. Br J Surg. 1978 May;65(5):337-41 - PubMed
  121. Zentralbl Chir. 1978;103(5):291-303 - PubMed
  122. Scand J Gastroenterol. 1985 Jan;20(1):5-12 - PubMed
  123. Arch Intern Med. 1978 Apr;138(4):535-8 - PubMed
  124. Surg Gynecol Obstet. 1979 Feb;148(2):206-8 - PubMed
  125. Thromb Diath Haemorrh. 1968 Dec 31;20(3):409-14 - PubMed
  126. Ann Chir Gynaecol Fenn. 1972;61(5):284-7 - PubMed
  127. Br J Surg. 1974 Mar;61(3):177-82 - PubMed
  128. Med Welt. 1974 Dec 13;25(50):2106-11 - PubMed
  129. Nouv Presse Med. 1973 Nov 10;2(40):2692 - PubMed
  130. Zentralbl Chir. 1974 Jun 14;99(24):748-50 - PubMed
  131. Klin Med (Mosk). 1966 May;44(5):13-5 - PubMed
  132. Acta Chir Scand Suppl. 1967;378:97-102 - PubMed
  133. Med Klin. 1966 Aug 12;61(32):1254-7 - PubMed
  134. Nord Med. 1968 May 16;79(20):651-3 - PubMed
  135. Med J Aust. 1969 Jun 21;1(25):1284-5 - PubMed
  136. Scand J Gastroenterol. 1969;4(3):291-5 - PubMed
  137. Am J Dig Dis. 1967 Apr;12(4):409-12 - PubMed
  138. Ter Arkh. 1968 Oct;40(10):82-4 - PubMed
  139. Antibiotiki. 1969 Feb;14(2):174-8 - PubMed
  140. N Engl J Med. 1980 Oct 23;303(17):999-1000 - PubMed
  141. Can J Surg. 1980 Nov;23(6):578-80 - PubMed
  142. Ann Chir Gynaecol. 1980;69(6):293-5 - PubMed
  143. Eur J Clin Pharmacol. 1981;21(1):17-21 - PubMed
  144. Res Exp Med (Berl). 1983;183(3):203-13 - PubMed
  145. World J Surg. 1984 Jun;8(3):354-9 - PubMed
  146. Am J Gastroenterol. 1980 May;73(5):423-5 - PubMed
  147. Rev Clin Esp. 1980 Sep 30;158(6):263-6 - PubMed
  148. Lancet. 1977 Sep 24;2(8039):632-5 - PubMed
  149. Br J Surg. 1995 Oct;82(10):1414-20 - PubMed
  150. Int J Pancreatol. 1993 Oct;14(2):117-24 - PubMed
  151. J Gastroenterol. 1994 Aug;29(4):479-85 - PubMed
  152. Ann Ital Chir. 1995 Mar-Apr;66(2):191-5 - PubMed
  153. Ann Surg. 1995 Jul;222(1):57-65 - PubMed
  154. J Am Coll Surg. 1995 Aug;181(2):121-4 - PubMed
  155. Lancet. 1995 Sep 9;346(8976):663-7 - PubMed
  156. Dig Dis Sci. 1995 Apr;40(4):734-8 - PubMed
  157. Ann Chir. 1976 Mar;30(3):201 - PubMed
  158. Ann Surg. 1976 Jun;183(6):667-71 - PubMed
  159. Int J Pancreatol. 1994 Apr;15(2):139-44 - PubMed
  160. Verh Dtsch Ges Inn Med. 1976;82 Pt 1:970-3 - PubMed
  161. Digestion. 1994;55 Suppl 1:20-3 - PubMed
  162. Dig Dis Sci. 1993 Apr;38(4):644-7 - PubMed
  163. Gastroenterology. 1993 Apr;104(4):1165-70 - PubMed
  164. Surg Gynecol Obstet. 1993 May;176(5):480-3 - PubMed
  165. Arch Surg. 1993 May;128(5):586-90 - PubMed
  166. Am J Gastroenterol. 1977 Jan;67(1):21-8 - PubMed
  167. Pancreas. 1996 Aug;13(2):198-201 - PubMed
  168. J Gastroenterol. 1996 Oct;31(5):702-9 - PubMed
  169. Int J Pancreatol. 1997 Feb;21(1):13-9 - PubMed
  170. Adv Exp Med Biol. 1996;416:361-3 - PubMed
  171. BMJ. 1997 Sep 13;315(7109):629-34 - PubMed
  172. Br J Surg. 1997 Sep;84(9):1239-43 - PubMed
  173. Surg Gynecol Obstet. 1976 Aug;143(2):209-19 - PubMed
  174. Scand J Gastroenterol. 1979;14(7):881-9 - PubMed
  175. Br J Surg. 1998 Feb;85(2):279-80 - PubMed
  176. Aliment Pharmacol Ther. 1998 Mar;12(3):237-45 - PubMed
  177. Nature. 1998 May 28;393(6683):299 - PubMed
  178. Int J Pancreatol. 1998 Aug;24(1):9-17 - PubMed
  179. Gastroenterology. 1998 Dec;115(6):1513-7 - PubMed

Substances

MeSH terms

Publication Types

Grant support